Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Tumor necrosis factor alpha

 B1AB92_HORSE            Unreviewed;       234 AA.
B1AB92;
08-APR-2008, integrated into UniProtKB/TrEMBL.
08-APR-2008, sequence version 1.
30-AUG-2017, entry version 71.
SubName: Full=Tumor necrosis factor alpha {ECO:0000313|EMBL:ABZ91988.1};
Equus caballus (Horse).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Laurasiatheria; Perissodactyla; Equidae; Equus.
NCBI_TaxID=9796;
[1] {ECO:0000313|EMBL:ABZ91988.1}
NUCLEOTIDE SEQUENCE.
Tompkins D., Hudgens T., Horohov D., Wagner B., Baldwin C.;
"U.S. Veterinary Immune Reagent Network: Expressed Equine Gene
Sequences.";
Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
-!- SUBUNIT: Homotrimer. {ECO:0000256|SAAS:SAAS00562244}.
-!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|SAAS:SAAS00568730}.
-!- SIMILARITY: Belongs to the tumor necrosis factor family.
{ECO:0000256|SAAS:SAAS00758062}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; EU438779; ABZ91988.1; -; mRNA.
RefSeq; NP_001075288.2; NM_001081819.2.
UniGene; Eca.13019; -.
ProteinModelPortal; B1AB92; -.
SMR; B1AB92; -.
GeneID; 100033834; -.
KEGG; ecb:100033834; -.
CTD; 7124; -.
eggNOG; ENOG410ISAN; Eukaryota.
eggNOG; ENOG410YQC4; LUCA.
HOVERGEN; HBG012516; -.
KO; K03156; -.
OMA; PWYEPIY; -.
OrthoDB; EOG091G0HIG; -.
Bgee; ENSECAG00000001174; -.
ExpressionAtlas; B1AB92; baseline.
GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW.
GO; GO:0005887; C:integral component of plasma membrane; IEA:Ensembl.
GO; GO:0045121; C:membrane raft; IEA:Ensembl.
GO; GO:0001891; C:phagocytic cup; IEA:Ensembl.
GO; GO:0055037; C:recycling endosome; IEA:Ensembl.
GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
GO; GO:0002020; F:protease binding; IEA:Ensembl.
GO; GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl.
GO; GO:0005164; F:tumor necrosis factor receptor binding; IEA:Ensembl.
GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
GO; GO:0000187; P:activation of MAPK activity; IEA:Ensembl.
GO; GO:0000185; P:activation of MAPKKK activity; IEA:Ensembl.
GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
GO; GO:0071316; P:cellular response to nicotine; IEA:Ensembl.
GO; GO:0002439; P:chronic inflammatory response to antigenic stimulus; IEA:Ensembl.
GO; GO:0030866; P:cortical actin cytoskeleton organization; IEA:Ensembl.
GO; GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl.
GO; GO:0048566; P:embryonic digestive tract development; IEA:Ensembl.
GO; GO:0072577; P:endothelial cell apoptotic process; IEA:Ensembl.
GO; GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; IEA:Ensembl.
GO; GO:0090002; P:establishment of protein localization to plasma membrane; IEA:Ensembl.
GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl.
GO; GO:0006006; P:glucose metabolic process; IEA:Ensembl.
GO; GO:0006959; P:humoral immune response; IEA:Ensembl.
GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl.
GO; GO:0007254; P:JNK cascade; IEA:Ensembl.
GO; GO:0050901; P:leukocyte tethering or rolling; IEA:Ensembl.
GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl.
GO; GO:0097527; P:necroptotic signaling pathway; IEA:Ensembl.
GO; GO:0010693; P:negative regulation of alkaline phosphatase activity; IEA:Ensembl.
GO; GO:1903347; P:negative regulation of bicellular tight junction assembly; IEA:Ensembl.
GO; GO:0061048; P:negative regulation of branching involved in lung morphogenesis; IEA:Ensembl.
GO; GO:0002740; P:negative regulation of cytokine secretion involved in immune response; IEA:Ensembl.
GO; GO:0001937; P:negative regulation of endothelial cell proliferation; IEA:Ensembl.
GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
GO; GO:0046325; P:negative regulation of glucose import; IEA:Ensembl.
GO; GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl.
GO; GO:0032715; P:negative regulation of interleukin-6 production; IEA:Ensembl.
GO; GO:0050995; P:negative regulation of lipid catabolic process; IEA:Ensembl.
GO; GO:0045930; P:negative regulation of mitotic cell cycle; IEA:Ensembl.
GO; GO:0045662; P:negative regulation of myoblast differentiation; IEA:Ensembl.
GO; GO:0035509; P:negative regulation of myosin-light-chain-phosphatase activity; IEA:Ensembl.
GO; GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl.
GO; GO:0043242; P:negative regulation of protein complex disassembly; IEA:Ensembl.
GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
GO; GO:0045071; P:negative regulation of viral genome replication; IEA:Ensembl.
GO; GO:0030316; P:osteoclast differentiation; IEA:Ensembl.
GO; GO:2000334; P:positive regulation of blood microparticle formation; IEA:Ensembl.
GO; GO:0060559; P:positive regulation of calcidiol 1-monooxygenase activity; IEA:Ensembl.
GO; GO:2000343; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; IEA:Ensembl.
GO; GO:0045080; P:positive regulation of chemokine biosynthetic process; IEA:Ensembl.
GO; GO:0002876; P:positive regulation of chronic inflammatory response to antigenic stimulus; IEA:Ensembl.
GO; GO:0050715; P:positive regulation of cytokine secretion; IEA:Ensembl.
GO; GO:0031622; P:positive regulation of fever generation; IEA:Ensembl.
GO; GO:0051798; P:positive regulation of hair follicle development; IEA:Ensembl.
GO; GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; IEA:Ensembl.
GO; GO:0002925; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl.
GO; GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl.
GO; GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl.
GO; GO:0045416; P:positive regulation of interleukin-8 biosynthetic process; IEA:Ensembl.
GO; GO:0043507; P:positive regulation of JUN kinase activity; IEA:Ensembl.
GO; GO:1904999; P:positive regulation of leukocyte adhesion to arterial endothelial cell; IEA:Ensembl.
GO; GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IEA:Ensembl.
GO; GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IEA:Ensembl.
GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl.
GO; GO:0051533; P:positive regulation of NFAT protein import into nucleus; IEA:Ensembl.
GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IEA:Ensembl.
GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl.
GO; GO:0045672; P:positive regulation of osteoclast differentiation; IEA:Ensembl.
GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl.
GO; GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl.
GO; GO:0071803; P:positive regulation of podosome assembly; IEA:Ensembl.
GO; GO:0043243; P:positive regulation of protein complex disassembly; IEA:Ensembl.
GO; GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl.
GO; GO:2000010; P:positive regulation of protein localization to cell surface; IEA:Ensembl.
GO; GO:1901671; P:positive regulation of superoxide dismutase activity; IEA:Ensembl.
GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
GO; GO:0045994; P:positive regulation of translational initiation by iron; IEA:Ensembl.
GO; GO:1904707; P:positive regulation of vascular smooth muscle cell proliferation; IEA:Ensembl.
GO; GO:0000060; P:protein import into nucleus, translocation; IEA:Ensembl.
GO; GO:0043491; P:protein kinase B signaling; IEA:Ensembl.
GO; GO:0032800; P:receptor biosynthetic process; IEA:Ensembl.
GO; GO:0060693; P:regulation of branching involved in salivary gland morphogenesis; IEA:Ensembl.
GO; GO:1903140; P:regulation of establishment of endothelial barrier; IEA:Ensembl.
GO; GO:0051023; P:regulation of immunoglobulin secretion; IEA:Ensembl.
GO; GO:0050796; P:regulation of insulin secretion; IEA:Ensembl.
GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
GO; GO:0009615; P:response to virus; IEA:Ensembl.
GO; GO:0030730; P:sequestering of triglyceride; IEA:Ensembl.
GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IEA:Ensembl.
Gene3D; 2.60.120.40; -; 1.
InterPro; IPR006053; TNF.
InterPro; IPR002959; TNF_alpha.
InterPro; IPR021184; TNF_CS.
InterPro; IPR006052; TNF_dom.
InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
PANTHER; PTHR11471:SF46; PTHR11471:SF46; 1.
Pfam; PF00229; TNF; 1.
PRINTS; PR01234; TNECROSISFCT.
PRINTS; PR01235; TNFALPHA.
SMART; SM00207; TNF; 1.
SUPFAM; SSF49842; SSF49842; 1.
PROSITE; PS00251; TNF_1; 1.
PROSITE; PS50049; TNF_2; 1.
2: Evidence at transcript level;
Cytokine {ECO:0000256|SAAS:SAAS00562264};
Membrane {ECO:0000256|SAAS:SAAS00080915, ECO:0000256|SAM:Phobius};
Secreted {ECO:0000256|SAAS:SAAS00080914};
Transmembrane {ECO:0000256|SAAS:SAAS00080915,
ECO:0000256|SAM:Phobius};
Transmembrane helix {ECO:0000256|SAAS:SAAS00080915,
ECO:0000256|SAM:Phobius}.
TRANSMEM 30 55 Helical. {ECO:0000256|SAM:Phobius}.
DOMAIN 90 234 TNF_2. {ECO:0000259|PROSITE:PS50049}.
SEQUENCE 234 AA; 25469 MW; E79ACE91143DF373 CRC64;
MSTESMIRDV ELAEEELAKK AGGPQGSRRC LCLSLFSFLL VAGATTLFCL LHFGVIGPQR
EEQLPNAFQS INPLAQTLRS SSRTPSDKPV AHVVANPQAE GQLQWLSGRA NALLANGVKL
TDNQLVVPLD GLYLIYSQVL FKGQGCPSTH VLLTHTISRL AVSYPSKVNL LSAIKSPCHT
ESPEQAEAKP WYEPIYLGGV FQLEKGDQLS AEINQPNYLD FAESGQVYFG IIAL


Related products :

Catalog number Product name Quantity
20-321-175109 TUMOR NECROSIS FACTOR ALPHA (TNF-alpha) - MONOCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR ALPHA (TNF-alpha); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclona 0.1 mg
20-321-175090 TUMOR NECROSIS FACTOR-ALPHA (TNF-alpha) - MONOCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR-ALPHA (TNF-alpha); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclona 0.1 mg
20-321-175089 TUMOR NECROSIS FACTOR-ALPHA (TNF-alpha) - MONOCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR-ALPHA (TNF-alpha); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclona 0.1 mg
20-321-175110 TUMOR NECROSIS FACTOR ALPHA (TNF-alpha) - BIOTINYLATED MONOCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR ALPHA (TNF-alpha); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachec 0.05 mg
20-321-175107 TUMOR NECROSIS FACTOR ALPHA (TNF-alpha) - MONOCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR ALPHA (TNF-alpha); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclona 0.1 mg
20-321-175108 TUMOR NECROSIS FACTOR ALPHA (TNF-alpha) - BIOTINYLATED MONOCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR ALPHA (TNF-alpha); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachec 0.05 mg
20-271-80049 Tumor Necrosis Factor-alpha - Mouse Anti Human Tumor Necrosis Factor-alpha; TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclonal 0.5 mg
20-271-80049 Tumor Necrosis Factor-alpha - Mouse Anti Human Tumor Necrosis Factor-alpha; TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclonal 1 mg
20-663-48023 Tumor Necrosis Factor-alpha (mAHuTNF-a) - Mouse Anti Human Tumor Necrosis Factor-alpha (mAHuTNF-a); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclonal 1 mg
20-663-48023 Tumor Necrosis Factor-alpha (mAHuTNF-a) - Mouse Anti Human Tumor Necrosis Factor-alpha (mAHuTNF-a); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclonal 0.5 mg
18-321-177015 TUMOR NECROSIS FACTOR-alpha - POLYCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR-alpha; TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Polyclonal 0.1 mg
10-321-179006 TUMOR NECROSIS FACTOR ALPHA (E.Coli-DERIVED) - RECOMBINANT MOUSE TUMOR NECROSIS FACTOR ALPHA (E.Coli-DERIVED) (5x104 units); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachec 520 Units
10-321-179009 TUMOR NECROSIS FACTOR ALPHA (E.Coli-DERIVED) - RECOMBINANT HUMAN TUMOR NECROSIS FACTOR ALPHA (E.Coli-DERIVED) (5x104 units); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachec 520 Units
U0132r CLIA p75,p80 TNF-alpha receptor,Rat,Rattus norvegicus,Tnfr2,TNF-R2,TNF-RII,TNFR-II,Tnfrsf1b,Tumor necrosis factor receptor 2,Tumor necrosis factor receptor superfamily member 1B,Tumor necrosis factor 96T
E0132r ELISA p75,p80 TNF-alpha receptor,Rat,Rattus norvegicus,Tnfr2,TNF-R2,TNF-RII,TNFR-II,Tnfrsf1b,Tumor necrosis factor receptor 2,Tumor necrosis factor receptor superfamily member 1B,Tumor necrosis factor 96T
U0132h CLIA Homo sapiens,Human,p75,p80 TNF-alpha receptor,TNFBR,TNFR2,TNF-R2,TNF-RII,TNFR-II,TNFRSF1B,Tumor necrosis factor receptor 2,Tumor necrosis factor receptor superfamily member 1B,Tumor necrosis fact 96T
E0132h ELISA Homo sapiens,Human,p75,p80 TNF-alpha receptor,TNFBR,TNFR2,TNF-R2,TNF-RII,TNFR-II,TNFRSF1B,Tumor necrosis factor receptor 2,Tumor necrosis factor receptor superfamily member 1B,Tumor necrosis fac 96T
10-663-45249 Tumor Necrosis Factor Receptor Fusion Protein (TNFR) Human - Tumor necrosis factor receptor 2; TNF-R2; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; CD120b antigen; Etanercept N 0.05 mg
10-663-45249 Tumor Necrosis Factor Receptor Fusion Protein (TNFR) Human - Tumor necrosis factor receptor 2; TNF-R2; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; CD120b antigen; Etanercept N 0.01 mg
10-663-45249 Tumor Necrosis Factor Receptor Fusion Protein (TNFR) Human - Tumor necrosis factor receptor 2; TNF-R2; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; CD120b antigen; Etanercept N 1 mg
10-663-45120 Tumor Necrosis Factor-alpha (TNF-alpha) Murine - TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin N_A 0.02 mg
10-663-45232 Tumor Necrosis Factor-alpha (TNF-alpha) Porcine - TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin N_A 0.02 mg
10-663-45120 Tumor Necrosis Factor-alpha (TNF-alpha) Murine - TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin N_A 0.005 mg
10-663-45232 Tumor Necrosis Factor-alpha (TNF-alpha) Porcine - TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin N_A 0.005 mg
10-663-45120 Tumor Necrosis Factor-alpha (TNF-alpha) Murine - TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin N_A 1 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur